Autonomical and Hemodynamic Repercussions on Excentric Resistance in Different Intensities With Blood Flow Restriction
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03942510 |
Recruitment Status :
Active, not recruiting
First Posted : May 8, 2019
Last Update Posted : September 16, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Exercise | Other: eccentric exercise with blood flow restriction | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 60 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Investigator) |
Primary Purpose: | Other |
Official Title: | Autonomical and Hemodynamic Repercussions on Excentric Resistance in Different Intensities Associated With Blood Flow Restriction: a Randomized Clinical Trial |
Actual Study Start Date : | March 11, 2019 |
Actual Primary Completion Date : | October 17, 2019 |
Estimated Study Completion Date : | December 22, 2020 |

Arm | Intervention/treatment |
---|---|
Experimental: High intensity eccentric training
high intensity (80% isometric peak) eccentric training of the knee extensors in the isokinetic will be performed during 6 weeks, 3 times a week.
|
Other: eccentric exercise with blood flow restriction
High/low intensity eccentric training group (80% and 40% of isometric peak torque) with or not blood flow restriction. |
Experimental: High intensity eccentric training with blood flow restriction
high intensity (80% isometric peak) eccentric training of the knee extensors in the isokinetic associated with a pressure cuff placed in the proximal thigh (40% of absolute occlusion pressure) will be performed during 6 weeks, 3 times a week.
|
Other: eccentric exercise with blood flow restriction
High/low intensity eccentric training group (80% and 40% of isometric peak torque) with or not blood flow restriction. |
Experimental: Low intensity eccentric training
A low intensity (40% isometric peak) eccentric training of the knee extensors in the isokinetic will be performed during 6 weeks, 3 times a week.
|
Other: eccentric exercise with blood flow restriction
High/low intensity eccentric training group (80% and 40% of isometric peak torque) with or not blood flow restriction. |
Experimental: Low intensity eccentric training with blood flow restriction
A low intensity (40% isometric peak) eccentric training of the knee extensors in the isokinetic associated with a pressure cuff placed in the proximal thigh (40% of absolute occlusion pressure)will be performed during 6 weeks, 3 times a week.
|
Other: eccentric exercise with blood flow restriction
High/low intensity eccentric training group (80% and 40% of isometric peak torque) with or not blood flow restriction. |
- heart rate variability indices in the time domain [ Time Frame: Change from baseline at 3rd week and 6rd week ]mean HR, rMSSD and SDNN in ms
- heart rate variability indices analyzed in the Poincaré plot [ Time Frame: Change from baseline at 3rd week and 6rd week ]SD1 and SD2 in ms
- heart rate variability indices in the frequency domain [ Time Frame: Change from baseline at 3rd week and 6rd week ]LF and HF in nu and ms2
- vagal reentry [ Time Frame: Change from 1 day at 10 day and 18 day ]rMSSD of 30 seconds in ms
- heart rate recovery [ Time Frame: Change from 1 day at 10 day and 18 day ]the recovery heart rate (HRR) in the 1st (HRR1) and 2st (HRR2) minute [bpm]
- hemodynamic parameter [ Time Frame: through study completion, an average of 6 weeks ]heart rate [bpm]
- hemodynamic parameter [ Time Frame: through study completion, an average of 6 weeks ]systolic and diastolic blood pressure [mmHg]
- hemodynamic parameter [ Time Frame: through study completion, an average of 6 weeks ]respiratory rate [irpm]
- hemodynamic parameter [ Time Frame: through study completion, an average of 6 weeks ]peripheral oxygen saturation [%]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 35 Years (Adult) |
Sexes Eligible for Study: | Male |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- male sex;
- healthy;
- aged between 18 and 35 years
Exclusion Criteria:
- smokers;
- alcoholics;
- use drugs that influenced cardiac autonomic activity;
- cardiovascular, metabolic or endocrine diseases.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03942510
Brazil | |
Leonardo Kesrouani Lemos | |
Presidente Prudente, SP, Brazil, 19050-050 |
Principal Investigator: | Franciele M Vanderlei, PhD | Paulista State University |
Responsible Party: | Franciele Marques Vanderle, Principal Investigator, Paulista University |
ClinicalTrials.gov Identifier: | NCT03942510 |
Other Study ID Numbers: |
U1111-1232-0808 |
First Posted: | May 8, 2019 Key Record Dates |
Last Update Posted: | September 16, 2020 |
Last Verified: | September 2020 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
resistance training vascular occlusion hemodynamics, cardiovascular system |
autonomic nervous system heart rate recovery of physiological function |